vs
Side-by-side financial comparison of STONERIDGE INC (SRI) and Bio-Techne (TECH). Click either name above to swap in a different company.
Bio-Techne is the larger business by last-quarter revenue ($295.9M vs $205.2M, roughly 1.4× STONERIDGE INC). On growth, STONERIDGE INC posted the faster year-over-year revenue change (-6.0% vs -6.4%). Over the past eight quarters, Bio-Techne's revenue compounded faster (4.2% CAGR vs -7.4%).
Stoneridge Inc is a global designer and manufacturer of advanced electrical and electronic components, integrated systems, and sensor solutions. It serves automotive, commercial vehicle, off-highway, and aerospace sectors, delivering products that boost vehicle safety, efficiency, connectivity, and environmental performance across key global markets.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
SRI vs TECH — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $205.2M | $295.9M |
| Net Profit | — | $38.0M |
| Gross Margin | 16.2% | 64.6% |
| Operating Margin | -14.4% | 18.4% |
| Net Margin | — | 12.8% |
| Revenue YoY | -6.0% | -6.4% |
| Net Profit YoY | — | 68.3% |
| EPS (diluted) | $-2.76 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $205.2M | $295.9M | ||
| Q3 25 | $210.3M | — | ||
| Q2 25 | $228.0M | $317.0M | ||
| Q1 25 | $217.9M | $316.2M | ||
| Q4 24 | $218.2M | $297.0M | ||
| Q3 24 | $213.8M | $289.5M | ||
| Q2 24 | $237.1M | $306.1M | ||
| Q1 24 | $239.2M | $303.4M |
| Q4 25 | — | $38.0M | ||
| Q3 25 | $-9.4M | — | ||
| Q2 25 | $-9.4M | $-17.7M | ||
| Q1 25 | $-7.2M | $22.6M | ||
| Q4 24 | — | $34.9M | ||
| Q3 24 | $-7.1M | $33.6M | ||
| Q2 24 | $2.8M | $40.6M | ||
| Q1 24 | $-6.1M | $49.1M |
| Q4 25 | 16.2% | 64.6% | ||
| Q3 25 | 20.3% | — | ||
| Q2 25 | 21.5% | 62.7% | ||
| Q1 25 | 21.2% | 67.9% | ||
| Q4 24 | 19.5% | 65.3% | ||
| Q3 24 | 20.8% | 63.2% | ||
| Q2 24 | 22.7% | 66.4% | ||
| Q1 24 | 20.2% | 67.4% |
| Q4 25 | -14.4% | 18.4% | ||
| Q3 25 | -1.6% | — | ||
| Q2 25 | -1.1% | -7.5% | ||
| Q1 25 | -1.5% | 12.2% | ||
| Q4 24 | -2.0% | 16.0% | ||
| Q3 24 | 0.1% | 13.8% | ||
| Q2 24 | 1.4% | 15.0% | ||
| Q1 24 | 0.1% | 22.1% |
| Q4 25 | — | 12.8% | ||
| Q3 25 | -4.5% | — | ||
| Q2 25 | -4.1% | -5.6% | ||
| Q1 25 | -3.3% | 7.1% | ||
| Q4 24 | — | 11.7% | ||
| Q3 24 | -3.3% | 11.6% | ||
| Q2 24 | 1.2% | 13.3% | ||
| Q1 24 | -2.6% | 16.2% |
| Q4 25 | $-2.76 | $0.24 | ||
| Q3 25 | $-0.34 | — | ||
| Q2 25 | $-0.34 | $-0.11 | ||
| Q1 25 | $-0.26 | $0.14 | ||
| Q4 24 | $-0.22 | $0.22 | ||
| Q3 24 | $-0.26 | $0.21 | ||
| Q2 24 | $0.10 | $0.26 | ||
| Q1 24 | $-0.22 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $66.3M | $172.9M |
| Total DebtLower is stronger | $180.9M | $260.0M |
| Stockholders' EquityBook value | $179.8M | $2.0B |
| Total Assets | $551.2M | $2.5B |
| Debt / EquityLower = less leverage | 1.01× | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $66.3M | $172.9M | ||
| Q3 25 | $54.0M | — | ||
| Q2 25 | $49.8M | $162.2M | ||
| Q1 25 | $79.1M | $140.7M | ||
| Q4 24 | $71.8M | $177.5M | ||
| Q3 24 | $54.1M | $187.5M | ||
| Q2 24 | $42.1M | $152.9M | ||
| Q1 24 | $48.4M | $145.3M |
| Q4 25 | $180.9M | $260.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $346.0M | ||
| Q1 25 | — | $330.0M | ||
| Q4 24 | $201.6M | $300.0M | ||
| Q3 24 | — | $300.0M | ||
| Q2 24 | — | $319.0M | ||
| Q1 24 | — | $389.0M |
| Q4 25 | $179.8M | $2.0B | ||
| Q3 25 | $251.2M | — | ||
| Q2 25 | $260.5M | $1.9B | ||
| Q1 25 | $253.1M | $2.0B | ||
| Q4 24 | $245.3M | $2.1B | ||
| Q3 24 | $271.4M | $2.1B | ||
| Q2 24 | $270.5M | $2.1B | ||
| Q1 24 | $277.3M | $2.0B |
| Q4 25 | $551.2M | $2.5B | ||
| Q3 25 | $632.1M | — | ||
| Q2 25 | $639.4M | $2.6B | ||
| Q1 25 | $657.4M | $2.6B | ||
| Q4 24 | $621.6M | $2.7B | ||
| Q3 24 | $662.5M | $2.7B | ||
| Q2 24 | $666.7M | $2.7B | ||
| Q1 24 | $675.4M | $2.7B |
| Q4 25 | 1.01× | 0.13× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | 0.82× | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.8M | — |
| Free Cash FlowOCF − Capex | $2.6M | — |
| FCF MarginFCF / Revenue | 1.3% | — |
| Capex IntensityCapex / Revenue | 3.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $12.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.8M | — | ||
| Q3 25 | $3.6M | — | ||
| Q2 25 | $10.7M | $98.2M | ||
| Q1 25 | $10.9M | $41.1M | ||
| Q4 24 | $19.2M | $84.3M | ||
| Q3 24 | $10.8M | $63.9M | ||
| Q2 24 | $8.7M | $75.5M | ||
| Q1 24 | $9.1M | $81.0M |
| Q4 25 | $2.6M | — | ||
| Q3 25 | $-2.7M | — | ||
| Q2 25 | $7.4M | $93.3M | ||
| Q1 25 | $4.8M | $31.0M | ||
| Q4 24 | $14.0M | $77.5M | ||
| Q3 24 | $4.6M | $54.7M | ||
| Q2 24 | $1.5M | $57.5M | ||
| Q1 24 | $3.3M | $64.5M |
| Q4 25 | 1.3% | — | ||
| Q3 25 | -1.3% | — | ||
| Q2 25 | 3.3% | 29.4% | ||
| Q1 25 | 2.2% | 9.8% | ||
| Q4 24 | 6.4% | 26.1% | ||
| Q3 24 | 2.2% | 18.9% | ||
| Q2 24 | 0.6% | 18.8% | ||
| Q1 24 | 1.4% | 21.3% |
| Q4 25 | 3.0% | — | ||
| Q3 25 | 3.0% | — | ||
| Q2 25 | 1.4% | 1.5% | ||
| Q1 25 | 2.8% | 3.2% | ||
| Q4 24 | 2.4% | 2.3% | ||
| Q3 24 | 2.9% | 3.2% | ||
| Q2 24 | 3.0% | 5.9% | ||
| Q1 24 | 2.4% | 5.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.82× | ||
| Q4 24 | — | 2.42× | ||
| Q3 24 | — | 1.90× | ||
| Q2 24 | 3.11× | 1.86× | ||
| Q1 24 | — | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SRI
| Control Devices | $51.7M | 25% |
| Electronics | $38.0M | 19% |
| EE | $34.2M | 17% |
| SE | $28.6M | 14% |
| NL | $24.5M | 12% |
| Stoneridge Brazil | $14.1M | 7% |
| Asia Pacific | $13.1M | 6% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
